350 related articles for article (PubMed ID: 30761303)
1. Intracellular Streptococcal Uptake and Persistence: A Potential Cause of Erysipelas Recurrence.
Jendoubi F; Rohde M; Prinz JC
Front Med (Lausanne); 2019; 6():6. PubMed ID: 30761303
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chronic recurrent erysipelas with streptococcal vaccine].
Haustein UF; Biella U; Tausch I; Knöll H
Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550
[TBL] [Abstract][Full Text] [Related]
3. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg.
Damstra RJ; van Steensel MA; Boomsma JH; Nelemans P; Veraart JC
Br J Dermatol; 2008 Jun; 158(6):1210-5. PubMed ID: 18363756
[TBL] [Abstract][Full Text] [Related]
4. Severe relapsing erysipelas associated with chronic Streptococcus agalactiae vaginal colonization.
Del Giudice P; van der Mee-Marquet N; David-Rubin F; Le Duff F; Benchia K; Counillon E; Domelier AS; Quentin R
Clin Infect Dis; 2006 Oct; 43(7):e67-70. PubMed ID: 16941357
[TBL] [Abstract][Full Text] [Related]
5. Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies.
Koster JB; Kullberg BJ; van der Meer JW
Neth J Med; 2007 Mar; 65(3):89-94. PubMed ID: 17387234
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
Vignes S; Dupuy A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
[TBL] [Abstract][Full Text] [Related]
7. Erysipelas: recognition and management.
Bonnetblanc JM; Bédane C
Am J Clin Dermatol; 2003; 4(3):157-63. PubMed ID: 12627991
[TBL] [Abstract][Full Text] [Related]
8. In Search of Risk Factors for Recurrent Erysipelas and Cellulitis of the Lower Limb: A Cross-Sectional Study of Epidemiological Characteristics of Patients Hospitalized due to Skin and Soft-Tissue Infections.
Sapuła M; Krankowska D; Wiercińska-Drapało A
Interdiscip Perspect Infect Dis; 2020; 2020():1307232. PubMed ID: 32454817
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of erysipelas prophylaxis depends on the cumulative dose of benzathine penicillin G.
Bednarska A; Sosińska-Bryła I; Grąbczewski P; Podlasin R; Paciorek M; Bursa D; Hackiewicz M; Makowiecki M; Horban A
Dermatol Reports; 2022 Sep; 14(3):9429. PubMed ID: 36199905
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies to type antigens of group A streptococcal cell walls in erysipelas patients].
Cherkasov VL; Chistenkov NA
Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):68-73. PubMed ID: 1092110
[TBL] [Abstract][Full Text] [Related]
11. [Infectious complications of lymphedema].
Vaillant L; Gironet N
Rev Med Interne; 2002 Jun; 23 Suppl 3():403s-407s. PubMed ID: 12162204
[TBL] [Abstract][Full Text] [Related]
12. [Primary and secondary prevention for erysipelas].
Becq-Giraudon B
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367
[TBL] [Abstract][Full Text] [Related]
13. Frequent colonization of betahaemolytic streptococci at various body sites including the perineum and anal canal during erysipelas and cellulitis.
Eriksson BKG; Karkkonen K; Jorup-Rönström C; Wretlind B
Infect Dis (Lond); 2019 Jul; 51(7):534-540. PubMed ID: 31088328
[No Abstract] [Full Text] [Related]
14. [The importance of local factors in recurrent erysipelas].
Stöberl C
Z Hautkr; 1985 May; 60(9):712, 715-8, 721-3. PubMed ID: 4013460
[TBL] [Abstract][Full Text] [Related]
15. [How I prevent erysipelas and its consequences and recurrences].
Henry F; Salomon-Neira MD; Letot B; Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2004; 59(7-8):423-5. PubMed ID: 15493153
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis in recurrent erysipelas.
Sjöblom AC; Eriksson B; Jorup-Rönström C; Karkkonen K; Lindqvist M
Infection; 1993; 21(6):390-3. PubMed ID: 8132369
[TBL] [Abstract][Full Text] [Related]
17. Erysipelas of the upper extremity following locoregional therapy for breast cancer.
El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO
Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307
[TBL] [Abstract][Full Text] [Related]
18. Erysipelas or cellulitis with a prosthetic joint
Wouthuyzen-Bakker M; Lora-Tamayo J; Senneville E; Scarbourough M; Ferry T; Uçkay I; Salles MJ; O'Connell K; Iribarren JA; Vigante D; Trebse R; Arvieux C; Soriano A; Ariza J;
J Bone Jt Infect; 2018; 3(4):222-225. PubMed ID: 30416947
[TBL] [Abstract][Full Text] [Related]
19. [Combined penicillin-streptococcal vaccine treatment of chronically recurring erysipelas].
Tausch I; Haustein UF; Knöll H; Köhler W
Dermatol Monatsschr; 1975 Nov; 161(11):936-42. PubMed ID: 1204905
[No Abstract] [Full Text] [Related]
20. [Elephantiasis nostras. A rare complication to erysipelas].
Jensen LP; Thomsen K; Schroeder TV
Ugeskr Laeger; 1991 Feb; 153(6):440-1. PubMed ID: 2000652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
